We just received data on a new analyst forecast for $BJ. BTIG gave a rating of 'Buy' for $BJ.
$BJ Analyst Ratings
Wall Street analysts have issued reports on $BJ in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/15/2025
- Citigroup issued a "Buy" rating on 08/18/2025
- UBS issued a "Buy" rating on 05/23/2025
- DA Davidson issued a "Buy" rating on 05/23/2025
- Baird issued a "Outperform" rating on 05/23/2025
- Wells Fargo issued a "Overweight" rating on 05/23/2025
To track analyst ratings and price targets for $BJ, check out Quiver Quantitative's $BJ forecast page.
$BJ Price Targets
Multiple analysts have issued price targets for $BJ recently. We have seen 11 analysts offer price targets for $BJ in the last 6 months, with a median target of $120.0.
Here are some recent targets:
- Robert Drbul from BTIG set a target price of $120.0 on 10/15/2025
- Greg Melich from Evercore ISI Group set a target price of $105.0 on 10/07/2025
- Paul Lejuez from Citigroup set a target price of $115.0 on 08/25/2025
- Mark Carden from UBS set a target price of $125.0 on 08/25/2025
- Michael Baker from DA Davidson set a target price of $123.0 on 08/25/2025
- Simeon Gutman from Morgan Stanley set a target price of $115.0 on 08/25/2025
- Christopher Horvers from JP Morgan set a target price of $110.0 on 08/25/2025
$BJ Congressional Stock Trading
Members of Congress have traded $BJ stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BJ stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY purchased up to $15,000 on 08/25.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/11 and 1 sale worth up to $15,000 on 07/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BJ Insider Trading Activity
$BJ insiders have traded $BJ stock on the open market 26 times in the past 6 months. Of those trades, 2 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $BJ stock by insiders over the last 6 months:
- ROBERT W. EDDY (President & CEO) has made 0 purchases and 19 sales selling 107,400 shares for an estimated $11,349,197.
- PAUL CICHOCKI (EVP, Chief Commercial Officer) has made 0 purchases and 3 sales selling 102,261 shares for an estimated $11,106,576.
- ROBERT ALLAN STEELE sold 9,815 shares for an estimated $1,101,341
- GRAHAM LUCE (EVP, Secretary) sold 6,300 shares for an estimated $629,118
- STEVEN L ORTEGA has made 2 purchases buying 3,820 shares for an estimated $399,271 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BJ Hedge Fund Activity
We have seen 325 institutional investors add shares of $BJ stock to their portfolio, and 297 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMUNDI removed 4,765,588 shares (-98.4%) from their portfolio in Q2 2025, for an estimated $513,873,354
- VICTORY CAPITAL MANAGEMENT INC added 2,192,358 shares (+74.4%) to their portfolio in Q2 2025, for an estimated $236,401,963
- WELLINGTON MANAGEMENT GROUP LLP added 1,336,948 shares (+118.7%) to their portfolio in Q2 2025, for an estimated $144,163,102
- FMR LLC removed 1,063,848 shares (-8.1%) from their portfolio in Q2 2025, for an estimated $114,714,729
- FIDUCIARY MANAGEMENT INC /WI/ removed 906,232 shares (-54.1%) from their portfolio in Q2 2025, for an estimated $97,718,996
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 905,778 shares (+4711.7%) to their portfolio in Q2 2025, for an estimated $97,670,041
- THRIVENT FINANCIAL FOR LUTHERANS removed 734,423 shares (-97.5%) from their portfolio in Q2 2025, for an estimated $79,192,832
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
